STAAR Surgical ICL Sales Up 67%; Company Raises Outlook for 2018
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
STAAR Surgical (STAA) Tops Q2 EPS by 10c, Revenues Beat; Boosts Outlook
August 1, 2018 4:06 PM EDTSTAAR Surgical (NASDAQ: STAA) reported Q2 EPS of $0.09, $0.10 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $33.9 million versus the consensus estimate of $26.74 million.
Second Quarter 2018 Overview
Net Sales of $33.9 Million Up 55% from the Prior Year QuarterICL Sales Up 67% and Units Up 66% from the Prior Year QuarterOther Sales Up 18% from the Prior Year QuarterGross Margin at 74.4% of Sales from 70.5% of Sales in the Prior Year... More